More recently, the nonsynonymous rs58542926 variant located in the transmembrane 6 superfamily member 2 (TM6SF2) gene has emerged as the second genetic determinant of NAFLD in terms of importance [6, 7]. Here, TM6SF2 is linked to metabolic dysfunction-associated steatotic liver disease.